USING 18F-FLUOROAZOMYCIN ARABINOSIDE TO NON-INVASIVELY IMAGE HYPOXIA IN MOUSE TUMOURS
DUAL ASSESSMENT OF HUMAN GLIOMA INVASION IN ORGANOTYPIC RAT BRAIN SLICE CULTURES BY TIME-LAPSE FLUORESCENCE MICROSCOPY AND IMMUNOHISTOCHEMISTRY
THE SEROLOGICAL MARKERS TIMP-1, PAI-1, MASP-2 AND CRP ARE INDEPENDENT PREDICTORS OF COLORECTAL CANCER-SPECIFIC DEATH
INTRATUMOURAL GENETIC HETEROGENEITY OF BREAST CARCINOMAS
NATURALLY ACQUIRED AND VACCINE INDUCED T-CELL RESPONSES IN CANCER PATIENTS
BIRTH WEIGHT AND RISK OF CANCER
THE MATRIX METALLOPROTEASE (MMP) INHIBITOR GALARDIN DIMINISHES SPONTANEOUS METASTASIS IN THE MMTV-PymT TRANSGENIC BREAST CANCER MODEL
ISOLATION OF SELECTIVE INHIBITORS OF HUMAN AND MURINE uPA FROM PHAGE-DISPLAYED PEPTIDE LIBRARIES
STROMA CELL DERIVED S100A4(Mts1) IN MOUSE TUMORS
RPTPα CONTROLS A SPECIFIC SUBSET OF PDGF SIGNALING IN FIBROBLASTS
THE POLYCOMB GROUP PROTEIN CBX8 IS AN ESSENTIAL REGULATOR OF GROWTH IN NORMAL AND CANCER CELLS
TIP60 RELOCALIZES Mdm2 TO THE PML ONCOGENIC DOMAINS, LEADING TO DECREASED Nedd8 CONJUGATION AND ENHANCED STABILITY OF p53 AND Mdm2
SIRAMESINE, A PROMISING NEW ANTI-CANCER DRUG THAT INDUCES LYSOSOMAL STRESS
THE ROLE OF GENE RAI IN APOPTOSIS AND CANCER
TRANSCRIPTIONALLY TARGETED CANCER GENE THERAPY FOR SMALL CELL LUNG CANCER
IMPACT OF ELECTIVE RESECTION ON PLASMA MMP-2, MMP-9 and TIMP-1 LEVELS IN PATIENTS WITH COLON CANCER
EVIDENCE FOR INVOLVEMENT OF COLONALLY EXPANDED CD8+T CELLS IN ANTI-CANCER IMMUNE RESPONSES IN CLL PATIENTS FOLLOWING NONMYELOABLATIVE CONDITIONING AND HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
THE HUMAN ACHAETE SCUTE HOMOLOG 1 PROMOTER - A CANDIDATE FOR TRANSCRIPTIONALLY REGULATED GENE THERAPY OF SMALL CELL LUNG CANCER
EphA2 BINDS TO ACTIVATED EGFR AND INHIBITS EGF INDUCED CANCER CELL MIGRATION
HEREGULIN-a1 STIMULATES CLEAVAGE OF ErbB2
A TRANSGENIC MOUSE MODEL FOR ANALYZING THE ROLE OF TOPOISOMERASE II IN MEDIATING THE PHARMACOLOGICAL EFFECTS OF DEXRAZOXANE
COMPLEMENTARY FUNCTION OF THE ENDOCYTIC RECEPTOR uPARAP AND EXTRACELLULAR COLLAGENOLYTIC PROTEASES IN THE DEGRADATION OF COLLAGEN IN VIVO
EXTRACELLULAR AND ENDOCYTIC ROUTES IN THE TURNOVER OF COLLAGENS
TARGETING OF PLASMINOGEN ACTIVATION IN MMTV-PymT TRANSGENIC BREAST CANCER AND IN SKIN WOUND HEALING
CHARACTERIZATION OF A P388 CELL LINE RESISTANT TO THE HISTONE DEACETYLASE INHIBITOR PXD101
BLOCKING CELLULAR COLLAGEN DEGRADATION WITH MONOCLONAL ANTIBODIES AGAINST uPARAP/Endo180
MMP-13 IN BREAST CARCINOGENESIS AND SKIN WOUND HEALING
EXPRESSION OF PAI-1 IN HUMAN COLORECTAL CANCER AND THEIR MATCHED LIVER METASTASES
CHARACTERIZATION OF THE FUNCTIONAL EPITOPE ON uPAR FOR uPA. COMPLETE ALANINE SCANNING MUTAGENESIS OF uPAR SUPPLEMENTED BY CHEMICAL CROSSLINKING
A NEW TAGGING SYSTEM FOR PRODUCTION OF RECOMBINANT PROTEINS IN DROSOPHILA S2 CELLS USING THE THIRD DOMAIN OF THE UROKINASE RECEPTOR
ACTIVITY OF THE EPIDERMAL GROWTH FACTOR RECEPTOR MODULATES CALCIUM-INDUCED APOPTOSIS THROUGH Akt/PI3KAND PLCg PATHWAYS IN BLADDER CANCER CELLS
THE INTERACTION BETWEEN VITRONECTIN AND UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (uPAR) ON INTACT CELLS
GENE AMPLIFIED IN SQUAMOUS CELL CARCINOMA 1 DEMETHYLATES TRI- AND DI-METHYLATED LYSINE 9 ON HISTONE H3
ASSOCIATION BETWEEN BLOOD LEVELS OF uPAR CLEAVAGE PRODUCTS AND SURVIVAL OF LUNG CANCER PATIENTS
THE REGULATORY MECHANISM(S) OF S100A4 MEDIATED MMP-13 ACTIVATION
MOLECULAR PROFILING OF ADAM12 IN HUMAN BLADDER CANCER
STRATEGY FOR USING FUNCTION-INHIBITING PEPTIDES FOR THE IDENTIFICATION OF THE RECEPTOR OF S100A4
Hsp70-2 CONTROLS THE EXPRESSION LEVEL OF A POTENT CANCER CELL SURVIVAL PROTEIN, LENS EPITHELIUM DERIVED GROWTH FACTOR (LEDGF/p75)
IDENTIFICATION OF TUMOR-DERIVED FACTOR(S), TDF, IMPLICATED IN PRO-TUMORIGENIC ACTIVATION OF STROMA CELLS
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2 IS A MARKER FOR ANTIESTROGEN RESISTANT HUMAN BREAST CANCER CELL LINES BUT IS NOT A MAJOR GROWTH REGULATOR
C-Jun N-TERMINAL KINASE SIGNALING IN Ras TRANSFORMATION
JNK2 ISOFORM OF JNK IS NECESSARY FOR TRANSMISSION OF TUMORIGENIC Ras SIGNALING
INHIBITION OF MOUSE uPA ACTIVITY BY MONOCLONAL ANTIBODIES AGAINST MOUSE uPA
GENERATION AND CHARACTERIZATION OF MURINE MONOCLONAL ANTIBODIES AGAINST MURINE uPAR
ADAM12 IS A FOUR-LEAFED CLOVER THE EXCISED PRODOMAIN REMAINS BOUND TO THE MATURE ENZYME
ANALYSIS OF MOLECULAR INTERACTIONS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 BY MONOCLONAL ANTIBODIES
TISSUE INHIBITOR OF METALLOPROTEINASES 1 (TIMP-1) AS AN IMMUNOHISTOCHEMICAL MARKER FOR THE EARLY DETECTION OF COLORECTAL CANCER
MACROPHAGE RECRUITMENT INTO TUMOURS AND INCREASED RELEASE OF CHEMO-ATTRACTING MOLECULES AFTER IONIZATION RADIATION
OXi 4503
THE USE OF DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING FOR EVALUATING THE EFFECTS OF COMBRETASTATIN A-4 DISODIUM PHOSPHATE IN DIFFERENTLY PERFUSED TUMOUR AREAS
LOSS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION AFFECTS THE INVOLVEMENT OF EFFECTOR-CASPASES IN ETOPOSIDE INDUCED APOPTOSIS OF FIBROSARCOMA CELLS
COX-2 EXPRESSION BY DUCTAL BREAST CANCER CORRELATES WITH INFILTRATION OF REGULATORY T CELLS
MOLECULAR CLASSIFICATION OF BREAST CANCER
MISMATCH REPAIR STATUS IN PRIMARY COLOREC-TAL TUMOURS AND DERIVED METASTASES
THE TUMOR SUPPRESSOR IRF-1 IS UPREGULATED BY ACTIVATED EGFR
FUNCTIONALITY, MAGNITUDE AND PHENOTYPE OF SPONTANEOUS PEPTIDE SPECIFIC T-CELL RESPONSES IN CANCER PATIENTS
CLEAVED uPAR; A POSSIBLE PREDICTOR OF RESPONSE IN NON-SMALL CELL LUNG CANCER TREATED WITH CHEMOTHERAPY
REGULATION OF A PROTEASE IMPLICATED IN CANCER INVASION AND METASTASIS
PLASMA TISSUE INHIBITOR OF METALLOPROTEIN-ASES-1 (TIMP-1) PREDICTS SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CANCER RECEIVING IRINOTECAN IN COMBINATION WITH 5FU AND FOLINIC ACID
TIMP-1 GENE DEFICIENCY INCREASES TUMOR CELL SENSITIVITY TO CHEMOTHERAPY INDUCED APOPTOSIS
FIRST DUAL-TARGET STEROID SULFATASE INHIBITOR AND SELECTIVE ESTROGEN RECEPTOR MODULATOR - A NOVEL APPROACH IN BREAST CANCER THERAPY
CHARACTERIZATION OF DNA MISMATCH REPAIR PROTEIN EXPRESSION, MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN PATIENTS WITH VULVAR CANCER
DISTINCT LIGAND-INDUCED CONFORMATIONS OF THE HUMAN OESTROGEN RECEPTOR DETECTED BY CONFORMATION-SPECIFIC PEPTIDE BINDING
A CASE-CONTROL STUDY OF CHEMOTHERAPY FOR 13 CASES OF ADENOCARCINOMA OF THE SMALL BOWEL COMPARED TO 65 MATCHED CONTROLS DERIVED FROM A DATABASE OF 581 PATIENTS WITH COLORECTAL CANCER
HIGH SERUM LEVEL OF YKL-40 IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH SHORT SURVIVAL
A NOVEL METHOD FOR MEASURING CELLULAR CYTOTOXICITY IN VITRO
CORRELATION BETWEEN ACUTE SKIN REACTION AND FATIGUE IN BREAST CANCER PATIENTS AFTER RADIOTHERAPY
MISMATCH REPAIR STATUS IN PRIMARY COLORECTAL TUMOURS AND DERIVED METASTASES
PROTEIN KINASE C ALPHA AS A POTENTIAL TARGET FOR ANTIESTROGEN RESISTANT BREAST CANCER
ACUTE PHASE REACTION FOLLOWING MAJOR SURGICAL TRAUMA
TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 IN PROSTATE CANCER
METHIMAZOLE EXACERBATES HARMFUL EFFECTS OF HYDROGEN PEROXIDE IN THYROID CELLS - A POSSIBLE INFLUENCE ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE
CHARACTERIZATION OF AN EPITHELIAL CELL LINE DERIVED FROM PATIENT WITH A STRONG FAMILY HISTORY OF BREAST CANCER
RESTRICTION OF GAGE PROTEIN EXPRESSION TO SUBPOPULATIONS OF CANCER CELLS IS INDEPENDENT OF GENOTYPE AND MAY LIMIT THE USE OF GAGE PROTEINS AS TARGETS FOR CANCER IMMUNOTHERAPY
TONSILLECTOMY, TONSILLITIS AND HODGKIN LYMPHOMA
THE PROTEIN KINASE RSK IS REQUIRED FOR INDUCTION OF EMT BY RECEPTOR TYROSINE KINASE SIGNALLING VIA THE RAS-ERK PATHWAY
BREAST ENDOTHELIAL CELLS INDUCE MESENCHYMAL TRANSITION IN AN EPITHELIAL CELL LINE WITH STEM CELL PROPERTIES
UUUUUAU MOTIFS IN THE 3ø UNTRANSLATED REGION OF HUMAN p53 INFLUENCE mRNA STABILITY AND TRANSLATION
GENERATION OF MONOCLONAL ANTIBODIES AGAINST THE MEMBRANE BOUND METALLOPROTEASE, MT1-MMP
Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of Northern Norway
Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum
Influence of angiogenesis inhibitors on endothelial cell morphology in vitro
Tyrosine kinase inhibitors alter adhesivity of prostatic cancer cells to extracellular matrix components
Gastric carcinosarcoma with neuroendocrine differentiation as the carcinoma component and leiomyosarcomatous and myofibroblastic differentiation as the sarcomatous component